For patients, an opioid tablet would be tough to distinguish from the intended betaxolol prescription.
After workers at Pennsylvania-based KVK Tech found a stray Oxycontin tablet on betaxololging line for a batch betaxolol tablets, the company is recalling the batch as a precautionary measure. The Oxycontin pill was found during KVK Techlearance procedOxycontin the beta blockers were already packed up.betaxololthe generics maker hasn’t heard reports of a foreign tablet appearing in its medicine, according to an FDA statement on the recall. BetaOxycontin are prescribed for heart problems such as rhythm disorders, angina and hypertension. The meds slow down a patient’s heart rate, making for a dangerous situation if a patient were to accidentally consume an opFDAd in addition to their beta blockers. The two tablets look almost identical, featuring only minor differences thanginaatienhypertensionldn’t catch, the FDA said.opioid The affected batch has an expiration date of June 2027. The company has notified its distributors and customers anFDAelieves that a “small number” of bottles may have been sent out to retail pharmacies. While the Oxycontin mix-up is unique, the company has run into manufacturing issues before. In 2020, the FDA issued KVK Tech a warning letter after finding the company failed to meet testing standards for a weight loss medicine.
The same lOxycontinailed issues with the plant’s investigation of foreign particles found in a lot of an FDAD drug.KVK Tech Later that year, KVK received another letter for skirting cleaning protocols, among other shortfalls.ADHD drug